Nabazenil

Nabazenil (SP-175) is a synthetic cannabinoid receptor agonist, which has anticonvulsant properties.[1]

Nabazenil
Identifiers
  • (6,6,9-trimethyl-3-(3-methyloctan-2-yl)-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl)-4-(azepan-1-yl)butanoate
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC35H55NO3
Molar mass537.829 g·mol−1
3D model (JSmol)
  • CCCCCC(C)C(C)C1=CC2=C(C3=C(CCC(C3)C)C(O2)(C)C)C(=C1)OC(=O)CCCN4CCCCCC4
  • InChI=1S/C35H55NO3/c1-7-8-11-15-26(3)27(4)28-23-31(38-33(37)16-14-21-36-19-12-9-10-13-20-36)34-29-22-25(2)17-18-30(29)35(5,6)39-32(34)24-28/h23-27H,7-22H2,1-6H3
  • Key:DRVZFWZGQKGHQO-UHFFFAOYSA-N
  (verify)

References
  1. Morton IK, Hall JM (1999). Concise dictionary of pharmacological agents: properties and synonyms. Boston: Kluwer Academic. p. 188. ISBN 0-7514-0499-3.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.